Effective April 2022, the Lucigen brand will start its final phases of transitioning to Biosearch Technologies, LGC’s comprehensive genomics portfolio. We are making this change because Biosearch Technologies unifies all legacy brands under one collective offer. This allows us to provide consistency across all of our products and services so we can deliver optimal support across our customers’ entire genomics workflow and at every stage of their product development pipeline.
The Lucigen website will eventually retire and become absorbed by Biosearch Technologies’ website and its subdomains. Our current target website retirement date is June 2022.
Browse our FAQs for more information about rebranding.
LGC has seen some considerable expansion and continues to grow its genomics portfolio. To help keep our customer’s mission critical project on target and moving quickly, LGC has brought together all of our genomics technologies into a single, unified portfolio – Biosearch Technologies.